Fri Sep 06 20:52:58 UTC 2024: – Eli Lilly and Pfizer have launched direct-to-consumer strategies for their pharmaceutical products
– The online experience is creating a sticky customer base in the health space
– Many patients prefer online experiences for acquiring prescriptions and drug delivery
– Successful online health platforms like GoodRx and Ro have high net promoter scores
– The direct-to-consumer strategy aims to increase sales and improve customer loyalty and satisfaction
– The strategy could upset the current prescription system dominated by insurers and PBMs
– The success of the strategy remains to be evaluated, but more companies are likely to adopt it
– The goal is to create a new model of vertical integration in healthcare
– It is uncertain how this strategy will impact the traditional model of prescription drugs

Read More